VTRS * Stock Overview
Operates as a healthcare company worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
Viatris Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$250.00 |
| 52 Week High | US$268.00 |
| 52 Week Low | US$160.69 |
| Beta | 0.93 |
| 11 Month Change | 11.11% |
| 3 Month Change | n/a |
| 1 Year Change | 55.58% |
| 33 Year Change | -7.06% |
| 5 Year Change | n/a |
| Change since IPO | -24.70% |
Recent News & Updates
Recent updates
Shareholder Returns
| VTRS * | MX Pharmaceuticals | MX Market | |
|---|---|---|---|
| 7D | 0% | -1.3% | -0.3% |
| 1Y | 55.6% | -19.3% | -4.0% |
Return vs Industry: VTRS * exceeded the MX Pharmaceuticals industry which returned -19.3% over the past year.
Return vs Market: VTRS * exceeded the MX Market which returned -4% over the past year.
Price Volatility
| VTRS * volatility | |
|---|---|
| VTRS * Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 6.7% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in MX Market | 6.1% |
| 10% least volatile stocks in MX Market | 2.7% |
Stable Share Price: VTRS *'s share price has been volatile over the past 3 months compared to the MX market.
Volatility Over Time: Insufficient data to determine VTRS *'s volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1961 | 32,000 | Scott Smith | www.viatris.com |
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs).
Viatris Inc. Fundamentals Summary
| VTRS * fundamental statistics | |
|---|---|
| Market cap | Mex$326.84b |
| Earnings (TTM) | -Mex$18.09b |
| Revenue (TTM) | Mex$308.20b |
1.1x
P/S Ratio-18.1x
P/E RatioIs VTRS * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VTRS * income statement (TTM) | |
|---|---|
| Revenue | US$15.05b |
| Cost of Revenue | US$8.72b |
| Gross Profit | US$6.32b |
| Other Expenses | US$7.21b |
| Earnings | -US$883.30m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.74 |
| Gross Margin | 42.03% |
| Net Profit Margin | -5.87% |
| Debt/Equity Ratio | 79.5% |
How did VTRS * perform over the long term?
See historical performance and comparisonDividends
3.6%
Current Dividend Yield-65%
Payout RatioDoes VTRS * pay a reliable dividends?
See VTRS * dividend history and benchmarks| Viatris dividend dates | |
|---|---|
| Ex Dividend Date | Nov 22 2024 |
| Dividend Pay Date | Dec 13 2024 |
| Days until Ex dividend | 2 days |
| Days until Dividend pay date | 19 days |
Does VTRS * pay a reliable dividends?
See VTRS * dividend history and benchmarks